Lord, Abbett & Co’s Veradigm Inc. Common Stock MDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-111,309
Closed -$2.51M 641
2022
Q1
$2.51M Buy
+111,309
New +$2.26M 0.01% 581
2014
Q4
Sell
-674,700
Closed -$9.05M 1001
2014
Q3
$9.05M Sell
674,700
-109,000
-14% -$1.65M 0.02% 623
2014
Q2
$12.6M Sell
783,700
-133,000
-15% -$2.07M 0.03% 598
2014
Q1
$16.5M Sell
916,700
-148,900
-14% -$2.58M 0.04% 523
2013
Q4
$16.5M Sell
1,065,600
-158,700
-13% -$2.34M 0.04% 573
2013
Q3
$18.2M Buy
+1,224,300
New +$18.5M 0.04% 539

Other funds holding MDRX

Lord, Abbett & Co's MDRX Position: Q2 2022 in Review

Lord, Abbett & Co sold out of Veradigm Inc. Common Stock (MDRX) in Q2 2022, closing a stake of 111,309 shares — an estimated $2.51M sold.

Lord, Abbett & Co first reported a position in MDRX in Q3 2013 and held it in 6 quarters. The position peaked at $18.2M in Q3 2013. 247 funds tracked by Wall St. Rank hold MDRX as of Q2 2022.

  • Lord, Abbett & Co reported no remaining Veradigm Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Lord, Abbett & Co sold 111,309 Veradigm Inc. Common Stock shares in Q2 2022, an estimated $2.51M.
  • Lord, Abbett & Co first reported a position in Veradigm Inc. Common Stock in Q3 2013 and held it in 6 quarters.
  • Lord, Abbett & Co's Veradigm Inc. Common Stock position peaked at $18.2M in Q3 2013.
  • 247 funds tracked by Wall St. Rank held Veradigm Inc. Common Stock as of Q2 2022.

Based on Lord, Abbett & Co's 13F filing for Q2 2022, filed 12 Aug 2022.